Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people.
about
Risk of "silent stroke" in patients older than 60 years: risk assessment and clinical perspectivesAssociation of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring StudyIs vascular depression a distinct sub-type of depressive disorder? A review of causal evidenceBlood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicabilityAsymptomatic cerebrovascular disease and systemic diagnosis in stroke, atherothrombosis as a disease of the vascular tree.Hypertensive encephalopathy in patients with chronic renal failure caused by stopping antihypertensive agents: a report of two cases.Dietary total fat intake and ischemic stroke risk: the Northern Manhattan StudyAssociation of methylenetetrahydrofolate reductase (MTHFR 677C>T and 1298A>C) polymorphisms and haplotypes with silent brain infarction and homocysteine levels in a Korean population.Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study.Lysophosphatidic acid level and the incidence of silent brain infarction in patients with nonvalvular atrial fibrillationSignificant association of metabolic syndrome with silent brain infarction in elderly people.Association of reduced folate carrier-1 (RFC-1) polymorphisms with ischemic stroke and silent brain infarction.The worldwide challenge of the dementias: a role for B vitamins and homocysteine?Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study.Alzheimer's disease and the Blood-Brain Barrier: Past, Present and Future.Improvement of the suture-occluded method in rat models of focal cerebral ischemia-reperfusion.Homocysteine, folate and cognition in a large community-based sample of elderly people--the 3C Dijon Study.Is homocysteine a causal and treatable risk factor for vascular diseases of the brain (cognitive impairment and stroke)?Association between cholesterols, homocysteine and silent brain infarcts.Homocysteine in neuropsychiatric disorders of the elderly.Homocysteine, white matter hyperintensities, and cognition in healthy elderly people.Circulating homocysteine levels in sustained and white coat hypertension.[Homocysteine and neuropsychiatric disorders].Silent cerebral infarction in patients with type 2 diabetic nephropathy. Effects of antiplatelet drug dilazep dihydrochloride.Homocysteine, type 2 diabetes mellitus, and cognitive performance: The Maine-Syracuse Study.Hyperhomocysteinemia is associated with volumetric white matter change in patients with small vessel disease.Distribution of etiologies in patients above and below age 45 with first-ever ischemic stroke.Correlations between folate, B12, homocysteine levels, and radiological markers of neuropathology in elderly post-stroke patients.Periventricular white matter lesions and sleep alteration in older people.Plasma homocysteine and risk of coexisting silent brain infarction in Alzheimer's disease.The Nutrition, Aging, and Memory in Elders (NAME) study: design and methods for a study of micronutrients and cognitive function in a homebound elderly population.Addiction research centres and the nurturing of creativity: the Kurihama medical and addiction centre-a profile.Pharmacogenetic study of methylenetetrahydrofolate reductase and thymidylate synthase in Japanese and assessment of ethnic and gender differences.
P2860
Q24610946-B5884C8C-B2EA-482D-BC41-3D52E112648FQ24658404-0E1698DC-E2E5-4292-AE64-520172B822A5Q28296493-B98F0C55-67E0-473D-B9E5-A77793E4308DQ28604099-C5BF8843-BC4B-4B90-8990-E8F31D8D0CE3Q31023308-FCF7935A-D879-45FF-A452-80785530D98FQ33518677-8E416D4E-EBBB-490D-857B-2DE1A5B9A2ECQ33668881-DF7EBF95-F34D-4B96-8E59-15E68584E6CBQ33670582-15E67375-AE0A-44CB-8569-B7F5F87E44EFQ34118216-77602151-8AA8-4D2E-B18C-F668362AF664Q34378059-8FCAEED1-FFEF-421A-8D6E-243D9242F240Q34987318-997C70E7-AD15-4510-9B04-7B70CAFD072CQ35057893-35075DA2-9D35-47D7-9E11-A3A2B6AEF633Q37246161-C1E65EDC-DFDA-46EB-BB24-3017405F39F1Q37265840-D5551EA5-0A68-40F5-9F5C-7EFBD4C0963EQ37422795-1C75B8FD-8FDA-4DC2-859C-B7BA6663A7B8Q37575130-CD36A402-3998-4F2A-A46E-B2D327FE0AE6Q39843661-9B5729EF-19BA-4DF6-9045-09692BDBB442Q43916603-3473749A-5714-474B-9E99-C44949DAF1F4Q44071299-C80CEFB8-264A-40D9-A307-F42DEF5BE98DQ44131619-FB6EB401-690C-48EC-81DE-0FF80A491326Q44296107-F3DBAE86-A89B-4E6A-828B-095EE0168EFEQ44354160-EAE6DDE3-085B-4707-87C4-4C8D2A44F34DQ44825250-E596D6D1-800B-48B2-A42C-F7E13CAA7C65Q45074013-7B38D86B-1C1B-47D5-834A-475F7205C645Q46729828-AD00705A-3147-4A62-86D7-135D05EFC8F6Q46788917-2AC70CEB-80AE-4CA4-935E-C2BA1B30A5AFQ46879745-88CD1C98-9E2B-464B-9B5B-6F767123242EQ48103362-0CF31B6B-AA9F-4C17-B287-9904DD5099A9Q48387543-1822EA08-54B1-4FDD-A54F-2D26F8EEA4D1Q48447054-9E1A5B2C-84EC-4B4F-A71A-CDA4FC2034E8Q48562887-5057BAB4-B4D4-4387-9A92-AB4B42946E82Q52303245-06B427EA-977E-48D3-BCF1-105357ABCDA7Q54565569-69E37075-6D83-4A5A-B383-CBAA8B2EB4A0
P2860
Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Elevated plasma homocysteine l ...... infarction in elderly people.
@ast
Elevated plasma homocysteine l ...... infarction in elderly people.
@en
type
label
Elevated plasma homocysteine l ...... infarction in elderly people.
@ast
Elevated plasma homocysteine l ...... infarction in elderly people.
@en
prefLabel
Elevated plasma homocysteine l ...... infarction in elderly people.
@ast
Elevated plasma homocysteine l ...... infarction in elderly people.
@en
P2093
P356
P1433
P1476
Elevated plasma homocysteine l ...... infarction in elderly people.
@en
P2093
M Morikawa
S Hashimoto
S Matsushita
P304
P356
10.1161/01.STR.32.5.1116
P407
P577
2001-05-01T00:00:00Z